CD4 and breast carcinoma: For example, regulatory CD4+ T cell (Treg) abundance has been calculated by the xCell algorithm from bulk tumor gene expression data of 5177 breast cancer patients from five independent cohorts, showing the potential of Treg abundance as a biomarker for predicting the response to NAC in TNBC (103).